Skip to main content
Top
Published in: Neurological Sciences 10/2018

01-10-2018 | Original Article

The serum level of inflammatory markers in chronic and episodic migraine: a case-control study

Authors: Fahimeh Martami, Soodeh Razeghi Jahromi, Mansoureh Togha, Zeinab Ghorbani, Maryam Seifishahpar, Atoosa Saidpour

Published in: Neurological Sciences | Issue 10/2018

Login to get access

Abstract

The exact mechanism of the migraine pathophysiology remained unclear. Although there are some reports showing low-grade inflammation in migraineurs, further studies are needed in this field. Thus, we designed a study to evaluate the serum levels of two main proinflammatory markers in migraine patients. In this case-control research, 43 migraine patients (23 chronic and 20 episodic migraineurs) and 40 age-sex-matched headache-free controls were studied. Demographic, dietary, and anthropometric data, headache characteristics, and serum C-reactive proteins (CRP) and tumor necrosis factor-alpha (TNF-α) assessments were collected. The mean ± SD age of the case and control groups were 36.98 ± 9.91 and 34.84 ± 9.75 years respectively. Compared to control subjects, both episodic and chronic migraineurs had significantly higher median levels of TNF-α (0.24, 0.95, and 1.90 pg/ml, respectively; P value < 0.001). Also, we observed a positive association between the TNF-α levels and the odds of having migraine after considering gender, age, body mass index, and dietary intakes of energy, carbohydrate, protein, fat, and mono and poly unsaturated fatty acids in the multivariable regression models (OR = 2.15; 95% CI 1.31–3.52; P value < 0.001). However, no significant association was demonstrated between migraine and serum CRP (OR = 2.91; 95% CI 0.87–9.78; P value = 0.08). These findings supported that inflammatory state could be related to the pathogenesis of migraine and it can thus be suggested that this effect might be beyond migraine progression. Further detailed studies are needed to investigate the importance of these findings in the pathogenesis of migraine headache.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arulmozhi D, Veeranjaneyulu A, Bodhankar S (2005) Migraine: current concepts and emerging therapies. Vasc Pharmacol 43(3):176–187CrossRef Arulmozhi D, Veeranjaneyulu A, Bodhankar S (2005) Migraine: current concepts and emerging therapies. Vasc Pharmacol 43(3):176–187CrossRef
2.
go back to reference Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner TJ, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210CrossRefPubMed Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner TJ, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210CrossRefPubMed
3.
go back to reference Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343–349CrossRefPubMed Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343–349CrossRefPubMed
5.
go back to reference Silberstein S, Olesen J, Bousser M, Diener H, Dodick D, First M et al (2005) International Headache Society. The international classification of headache disorders, (ichd-ii)—revision of criteria for 8.2 medication-overuse headache. Headache 45(10):1424–1425CrossRef Silberstein S, Olesen J, Bousser M, Diener H, Dodick D, First M et al (2005) International Headache Society. The international classification of headache disorders, (ichd-ii)—revision of criteria for 8.2 medication-overuse headache. Headache 45(10):1424–1425CrossRef
6.
go back to reference Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB (2013) Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health 16(1):31–38CrossRefPubMed Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB (2013) Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health 16(1):31–38CrossRefPubMed
7.
go back to reference Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790CrossRefPubMed Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790CrossRefPubMed
8.
go back to reference Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52(10):1456–1470CrossRefPubMed Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52(10):1456–1470CrossRefPubMed
9.
go back to reference Jahromi SR, Abolhasani M, Meysamie A, Togha M (2013) The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol 12(1):23–27PubMedPubMedCentral Jahromi SR, Abolhasani M, Meysamie A, Togha M (2013) The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol 12(1):23–27PubMedPubMedCentral
10.
go back to reference Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, Razeghi Jahromi S (2018) Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci 39(1):63–70CrossRefPubMed Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, Razeghi Jahromi S (2018) Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci 39(1):63–70CrossRefPubMed
11.
go back to reference Lance JW (1993) Current concepts of migraine pathogenesis. Neurology 43(6 Suppl 3):S11–S15PubMed Lance JW (1993) Current concepts of migraine pathogenesis. Neurology 43(6 Suppl 3):S11–S15PubMed
12.
go back to reference Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64(10 suppl 2):S9–S15CrossRefPubMed Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64(10 suppl 2):S9–S15CrossRefPubMed
13.
go back to reference Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5):304–311CrossRefPubMed Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5):304–311CrossRefPubMed
14.
go back to reference Bruno PP, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. European Review for Medical and Pharmacological Sciences 11(4):245–248PubMed Bruno PP, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. European Review for Medical and Pharmacological Sciences 11(4):245–248PubMed
15.
go back to reference Duarte H, Teixeira AL, Rocha NP, Domingues RB (2015) Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine. Neurol Sci 36(2):203–208CrossRefPubMed Duarte H, Teixeira AL, Rocha NP, Domingues RB (2015) Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine. Neurol Sci 36(2):203–208CrossRefPubMed
16.
go back to reference Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931CrossRefPubMed Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931CrossRefPubMed
17.
go back to reference Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200–207CrossRefPubMed Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200–207CrossRefPubMed
18.
go back to reference Boćkowski L, Sobaniec W, Żelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41(1):17–21CrossRefPubMed Boćkowski L, Sobaniec W, Żelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41(1):17–21CrossRefPubMed
19.
go back to reference Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, Guzel I, Islamoglu Y, Colpan L, Tasdemir N (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 15(10):1111–1116PubMed Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, Guzel I, Islamoglu Y, Colpan L, Tasdemir N (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 15(10):1111–1116PubMed
20.
go back to reference Tanik N, Celikbilek A, Metin A, Gocmen AY, Inan LE (2015) Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 36(10):1823–1827CrossRefPubMed Tanik N, Celikbilek A, Metin A, Gocmen AY, Inan LE (2015) Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 36(10):1823–1827CrossRefPubMed
21.
go back to reference Wang F, He Q, Ren Z, Li F, Chen W, Lin X, Zhang H, Tai G (2015) Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine. Neurol Sci 36(4):535–540CrossRefPubMed Wang F, He Q, Ren Z, Li F, Chen W, Lin X, Zhang H, Tai G (2015) Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine. Neurol Sci 36(4):535–540CrossRefPubMed
22.
go back to reference Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362PubMed Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362PubMed
23.
go back to reference Vanmolkot F, De Hoon J (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27(7):843–846CrossRefPubMed Vanmolkot F, De Hoon J (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27(7):843–846CrossRefPubMed
24.
go back to reference Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C et al (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol Scand 13(2):205–211 Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C et al (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol Scand 13(2):205–211
25.
go back to reference Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(2):s107–ss10CrossRefPubMed Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(2):s107–ss10CrossRefPubMed
26.
go back to reference Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E, Savastano S, Ghiggi MR, Tommaselli AP, Lombardi G (1991) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. Int J Neurosci 61(1–2):53–60CrossRefPubMed Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E, Savastano S, Ghiggi MR, Tommaselli AP, Lombardi G (1991) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. Int J Neurosci 61(1–2):53–60CrossRefPubMed
27.
go back to reference Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache 41(2):129–137CrossRefPubMed Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache 41(2):129–137CrossRefPubMed
28.
go back to reference Welch K, Brandes AW, Salerno L, Brandes JL (2006) C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 46(2):197–199CrossRefPubMed Welch K, Brandes AW, Salerno L, Brandes JL (2006) C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 46(2):197–199CrossRefPubMed
29.
go back to reference Gudmundsson LS, Aspelund T, Scher AI, Thorgeirsson G, Johannsson M, Launer LJ, Gudnason V (2009) C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29(12):1301–1310CrossRefPubMedPubMedCentral Gudmundsson LS, Aspelund T, Scher AI, Thorgeirsson G, Johannsson M, Launer LJ, Gudnason V (2009) C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29(12):1301–1310CrossRefPubMedPubMedCentral
30.
go back to reference Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1):184–188CrossRefPubMed Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1):184–188CrossRefPubMed
31.
go back to reference Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain 11(5):427–430CrossRefPubMedPubMedCentral Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain 11(5):427–430CrossRefPubMedPubMedCentral
32.
go back to reference Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M et al (2017) Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg 1–10 Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M et al (2017) Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg 1–10
33.
go back to reference Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-α and IL-12/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138–144CrossRefPubMed Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-α and IL-12/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138–144CrossRefPubMed
34.
go back to reference Kurth T, Ridker P, Buring J (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28(1):49–56CrossRefPubMed Kurth T, Ridker P, Buring J (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28(1):49–56CrossRefPubMed
35.
go back to reference Lippi G, Mattiuzzi C, Cervellin G (2014) C-reactive protein and migraine. Facts or speculations? Clin Chem Lab Med 52(9):1265–1272PubMed Lippi G, Mattiuzzi C, Cervellin G (2014) C-reactive protein and migraine. Facts or speculations? Clin Chem Lab Med 52(9):1265–1272PubMed
36.
go back to reference Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A et al (2017) Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia 0333102417720213 Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A et al (2017) Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia 0333102417720213
37.
go back to reference Empl M, Sostak P, Riedel M, Schwarz M, Müller N, Förderreuther S, Straube A (2003) Decreased sTNF-RI in migraine patients? Cephalalgia 23(1):55–58CrossRefPubMed Empl M, Sostak P, Riedel M, Schwarz M, Müller N, Förderreuther S, Straube A (2003) Decreased sTNF-RI in migraine patients? Cephalalgia 23(1):55–58CrossRefPubMed
38.
go back to reference Guldiken B, Guldiken S, Demir M, Turgut N, Kabayel L, Ozkan H, Ozcelik E, Tugrul A (2008) Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 35(4):448–451CrossRefPubMed Guldiken B, Guldiken S, Demir M, Turgut N, Kabayel L, Ozkan H, Ozcelik E, Tugrul A (2008) Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 35(4):448–451CrossRefPubMed
39.
go back to reference Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzmán JC, Morillo CA, Vesga B, Pradilla G, Flórez M, López-Jaramillo P (2007) Endothelial function in patients with migraine during the interictal period. Headache 47(1):45–51CrossRefPubMed Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzmán JC, Morillo CA, Vesga B, Pradilla G, Flórez M, López-Jaramillo P (2007) Endothelial function in patients with migraine during the interictal period. Headache 47(1):45–51CrossRefPubMed
40.
go back to reference Yilmaz N, Yilmaz M, Sirin B, Yilmaztekin S, Kutlu G (2017) The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura. J Recept Signal Transduct Res 37(5):447–452CrossRefPubMed Yilmaz N, Yilmaz M, Sirin B, Yilmaztekin S, Kutlu G (2017) The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura. J Recept Signal Transduct Res 37(5):447–452CrossRefPubMed
41.
go back to reference Heshmat-Ghahdarijani K, Javanmard SH, Sonbolestan SA, Saadatnia M, Sonbolestan SA (2015) Endothelial function in patients with migraine without aura during the interictal period. Int J Prev Med 6:2CrossRefPubMedPubMedCentral Heshmat-Ghahdarijani K, Javanmard SH, Sonbolestan SA, Saadatnia M, Sonbolestan SA (2015) Endothelial function in patients with migraine without aura during the interictal period. Int J Prev Med 6:2CrossRefPubMedPubMedCentral
42.
go back to reference Mustafa C, Omer Faruk B, Sinan B, Ömer A, Ahmet Y, Dilcan K (2015) Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia 36(6):518–525 Mustafa C, Omer Faruk B, Sinan B, Ömer A, Ahmet Y, Dilcan K (2015) Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia 36(6):518–525
43.
go back to reference Hamed SA, Hamed EA, Eldin AME, Mahmoud NM (2010) Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis 19(2):92–103CrossRefPubMed Hamed SA, Hamed EA, Eldin AME, Mahmoud NM (2010) Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis 19(2):92–103CrossRefPubMed
44.
go back to reference Lord G, Duckworth J (1977) Immunoglobulin and complement studies in migraine. Headache 17(4):163–168CrossRefPubMed Lord G, Duckworth J (1977) Immunoglobulin and complement studies in migraine. Headache 17(4):163–168CrossRefPubMed
45.
go back to reference Martelletti P, Sutherland J, Anastasi E, Mario UD, Giacovazzo M (1989) Evidence for an immune-mediated mechanism in food-induced migraine from a study on activated T-cells, IgG 4 subclass, anti-lgG antibodies and circulating immune complexes. Headache 29(10):664–670CrossRefPubMed Martelletti P, Sutherland J, Anastasi E, Mario UD, Giacovazzo M (1989) Evidence for an immune-mediated mechanism in food-induced migraine from a study on activated T-cells, IgG 4 subclass, anti-lgG antibodies and circulating immune complexes. Headache 29(10):664–670CrossRefPubMed
46.
go back to reference Covelli V, Munno I, Pellegrino N, Di AV, Jirillo E, Buscaino G (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurologica 12(4):257–263PubMed Covelli V, Munno I, Pellegrino N, Di AV, Jirillo E, Buscaino G (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurologica 12(4):257–263PubMed
47.
go back to reference Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C, di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurologica 13(2):205–211PubMed Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C, di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurologica 13(2):205–211PubMed
48.
go back to reference Zhang X-C, Kainz V, Burstein R, Levy D (2011) Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. PAIN 152(1):140–149CrossRefPubMed Zhang X-C, Kainz V, Burstein R, Levy D (2011) Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. PAIN 152(1):140–149CrossRefPubMed
49.
go back to reference Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H (2016) Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20(5):930–936PubMed Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H (2016) Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20(5):930–936PubMed
Metadata
Title
The serum level of inflammatory markers in chronic and episodic migraine: a case-control study
Authors
Fahimeh Martami
Soodeh Razeghi Jahromi
Mansoureh Togha
Zeinab Ghorbani
Maryam Seifishahpar
Atoosa Saidpour
Publication date
01-10-2018
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 10/2018
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3493-0

Other articles of this Issue 10/2018

Neurological Sciences 10/2018 Go to the issue